CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Restatement
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 464,500 shares at an average $9.89 ($4,594,594)
- 4 Open-market buy Director bought 5,000 shares at $9.98 ($49,900)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- S-1 Offering Registration Statement
- 8-K/A Event Exhibits
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Option exercise Director acquired 25,000 shares (option exercise)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Option exercise Director acquired 25,000 shares (option exercise)
Page 16 of 20 · 400 filings